Death: Clinical Trials

57 trials for Death, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

57 completed. 57 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 357Completed 57
Phase 28Completed 8

Follow Death: new trials by email Literature Review of Death trials Research Report on Death

Trials (filtered) newest first · largest first

All 57 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone
Progesteron TID - IVF, Embryo Loss
Phase 3CompletedUniversity Hospital, Ghent872021-04-022026-03-23
Vitamin D for COVID-19 Trial
vitamin D, Placebo - COVID-19
Phase 3CompletedBrigham and Women's Hospital20242020-12-282025-09-24
Intravenous Thyroxine for Heart-Eligible Organ Donors
Thyroxine, Saline - Brain Death, Heart Failure
Phase 3CompletedWashington University School of Medicine8382020-12-012024-01-10
Micophenolate Mofetil Versus Azathioprine in Myocarditis
mycophenolate mofetil 2 g per day, azathioprine of 150 [75; 150] mg per day - Lymphocytic Myocarditis (Disorder), Heart Failure
Phase 3CompletedI.M. Sechenov First Moscow State Medical University502020-10-012025-07-15
Azithromycin-Prevention in Labor Use Study (A-PLUS)
Azithromycin, Placebo - Maternal Death, Maternal Infections Affecting Fetus or Newborn
Phase 3CompletedNICHD Global Network for Women's and Children's Health587472020-09-012024-10-24
The Use of Liraglutide in Brain Death
Liraglutide - Brain Death
Phase 3CompletedHospital de Clinicas de Porto Alegre502018-09-012024-03-05
An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)
Hunterase - MPS II, Hunter Syndrome (MPS II)
Phase 3CompletedGC Biopharma Corp302018-05-232026-01-15
A Study of GC1111 in Hunter Syndrom Patients
GC1111, Comparator - Hunter Syndrome
Phase 3CompletedGreen Cross Corporation322017-03-092024-04-16
Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients
Melatonin, Sugar pill - Delirium
Phase 3CompletedFraser Health192016-06-292021-08-26
Hydrocortisone Treatment In Systemic Low Blood Pressure During Hypothermia in Asphyxiated Newborns
Hydrocortisone, Placebo - Hypoxic-Ischemic Encephalopathy, Asphyxia
Phase 2 / Phase 3CompletedSemmelweis University322016-02-012023-04-21
A Comparison Between Home-made Vitrification & Thawing Media and a Commercially Available Brand on Blastocyst
home made vitrification & thawing kit, commercially made vitrification & thawing kit - Blastocyst Disintegration
Phase 2 / Phase 3CompletedBenha University742015-10-012018-09-07
Naloxone for Optimizing Hypoxemia Of Lung Donors
Naloxone, Normal saline - Brain Death, Organ Donors
Phase 2 / Phase 3CompletedWashington University School of Medicine1992015-09-012020-07-31
Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy
naloxone, Placebo - Epilepsy
Phase 3CompletedHospices Civils de Lyon4852015-06-262025-09-26
Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
Rosuvastatin, Placebo - ANCA-associated Primary Necrotizing Vasculitides
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1212014-10-272025-11-20
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
idursulfase-IT, No IT treatment - Hunter Syndrome
Phase 2 / Phase 3CompletedShire582014-03-242021-06-11
BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction
Bone Marrow aspiration and intracoronary reinfusion - Myocardial Infarction, Death
Phase 3CompletedQueen Mary University of London3752013-09-012021-04-13
Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients
RAD001, MMF - Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant
Phase 3CompletedNovartis Pharmaceuticals1062012-08-172019-05-31
Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients
Remote ischemic preconditioning stimulus, control - Death, Stroke
Phase 3CompletedQueen's University4292012-02-012016-02-05
Ranolazine Implantable Cardioverter-Defibrillator Trial
Ranolazine - Ischemic Cardiomyopathy, Nonischemic Cardiomyopathy
Phase 3CompletedUniversity of Rochester10122011-09-012018-08-27
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Implantable Cardioverter Defibrillator + Usual Care, Usual care - Myocardial Infarction, Sudden Death
Phase 3CompletedUniversity of Calgary7002011-04-182025-05-30

Showing 20 of 57. Sign in to see all of them.

Narrower conditions

Death, Sudden, Cardiac (17)  ·  Cardiovascular Diseases (10)  ·  Heart Diseases (10)  ·  Myocardial Infarction (10)  ·  Arrhythmias, Cardiac (9)  ·  Heart Failure (6)  ·  Sudden Infant Death (6)  ·  Heart Arrest (5)  ·  Infant Death (5)  ·  Mucopolysaccharidosis II (5)  ·  Ventricular Fibrillation (5)  ·  Asphyxia (4)  ·  Brain Death (4)  ·  Coronary Disease (4)

Broader conditions

Pathologic Processes (57)  ·  Pathological Conditions, Signs and Symptoms (57)  ·  Death, Sudden (25)  ·  Nervous System Diseases (18)  ·  Cardiovascular Diseases (17)  ·  Vascular Diseases (15)  ·  Heart Diseases (14)  ·  Female Urogenital Diseases and Pregnancy Complications (12)  ·  Heart Arrest (12)  ·  Neurologic Manifestations (12)  ·  Urogenital Diseases (12)  ·  Brain Diseases (11)  ·  Central Nervous System Diseases (11)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10)

Interventions

Defibrillators, Implantable (5)  ·  Amiodarone (3)  ·  Sodium Chloride (3)  ·  Sotalol (3)  ·  Aspirin (2)  ·  Folic Acid (2)  ·  Geritol (2)  ·  Iron (2)  ·  Naloxone (2)  ·  Ranolazine (2)  ·  Saline Solution (2)  ·  Vitamin A (2)  ·  idursulfase (2)  ·  Acetylcysteine (1)  ·  Ambulatory Care Facilities (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (8)  ·  Johns Hopkins Bloomberg School of Public Health (5)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Shire (3)  ·  Brigham and Women's Hospital (2)  ·  Hospices Civils de Lyon (2)  ·  NICHD Global Network for Women's and Children's Health (2)  ·  University of Calgary (2)  ·  Washington University School of Medicine (2)  ·  Aspirus Heart and Vascular Institute-Research and Education (1)  ·  Benha University (1)  ·  Campus Bio-Medico University (1)  ·  Centers for Disease Control and Prevention (1)  ·  ELA Medical, Inc. (1)  ·  Fraser Health (1)

Countries

United States (18)  ·  France (10)  ·  Canada (8)  ·  Spain (6)  ·  United Kingdom (6)  ·  Bangladesh (5)  ·  Brazil (5)  ·  Germany (5)  ·  Italy (5)  ·  Belgium (3)  ·  Finland (3)  ·  Hungary (3)  ·  India (3)  ·  Sweden (3)  ·  Argentina (2)

Top investigators

Alfred Hallstrom (2)  ·  Alfred Sommer, M.D. (2)  ·  Kerry Lee (2)  ·  Rajat Dhar, MD (2)  ·  Abdullah H Baqui, MBBS, DrPH (1)  ·  Alain B Labrique, MSc (1)  ·  Alain B. Labrique, MSc (1)  ·  Alain Cariou, MD, PhD (1)  ·  Alejandro Jenik, M.D. (1)  ·  Allan Barker (1)  ·  Andrew Levey, M.D. (1)  ·  Anthony Mathur, MD, FRCP, PhD (1)  ·  Bassam Haddad (1)

Results publications

PMID 28490513, PMID 12914883, PMID 18371559, PMID 18381485, PMID 18450889, PMID 18644934, PMID 19022547, PMID 19349375, PMID 19581544, PMID 19704100, PMID 19845951, PMID 19917887, PMID 20362722, PMID 20435345, PMID 20884379, PMID 20941903, PMID 20977661, PMID 21150784, PMID 21177506, PMID 21482964, PMID 21510905, PMID 21586714, PMID 21832026, PMID 21956955, PMID 22071710, PMID 22218721, PMID 22322124, PMID 22929184, PMID 23151532, PMID 23280225, PMID 23303315, PMID 23509175, PMID 23541974, PMID 23837440, PMID 23966331, PMID 24727258, PMID 25250647, PMID 25536256, PMID 25589197, PMID 25646326, PMID 25985774, PMID 26186135, PMID 26431336, PMID 26446483, PMID 27263403, PMID 27449568, PMID 27482002, PMID 27514751, PMID 27604769, PMID 27741174

NIH funding

2004 (1), 2014 (1), R01HL034071 (1), R01HL036821 (1), R01HL091157 (1), U01DK061700 (1), U01HD043464 (1), U01HL045700 (1), U01HL048120 (1), U01HL048159 (1), U01HL055766 (1), U01HL067972 (1), U24HD092094 (1)